SEC Form 4 · accession 0001209191-16-106849
U S PHYSICAL THERAPY INC /NV · USPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lawrance W McAfee
Officer — Chief Financial Officer · Director
Period of report
Mar 4, 2016
Accepted (ET)
Mar 8, 2016 · 10:36 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885978
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 4, 2016 | S | 5,000 | $52.74 | D | 45,212 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.74 - $52.75, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- F2Includes grant of 11,360 restricted shares granted under the Company's equity plan with a four-year quarterly vesting schedule as to the lapse of restrictions thereof with 1/16 equal portions (710 shares) vesting quarterly, with the next 1/16 vesting on April 1, 2016 and thereafter equal 1/16 portions on April 1, July 1, October 1 and January 1 each year with the final 710 shares on January 1, 2020. Also Includes 27,104 restricted shares granted under the Company's equity plan. Restrictions lapse as to 3,337 shares on April 1, 2016, July 1, 2016, October 1, 2016, January 1, 2017, 2187 on April 1, 2017, July 1, 2017, October 1, 2017; 2195 on January 1, 2018 and 1250 on April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019.